Clinical trials: MPN - Accelerated or Blast Phase
Accelerated Phase MPN, Blast Phase MPN
A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN
This is a multicenter, Phase 2 Simon 2-Stage study designed to assess the safety, tolerability, PK, and efficacy of oral zelavespib (PU-H71) administered daily in adults with accelerated phase (10% to 19% blasts in peripheral or…
- Trial name
- AP-MPN (NCT05612633)
- Testing
- zelavespib
- Sponsor
- Samus Therapeutics, Inc.